BIT225: HIV VPU Inhibitor Candidate
Contender in the Ring
A novel HIV therapy targets & eradicates one cell type in the viral reservoir
by Jeannie Wraight
BIT225, an HIV VPU inhibitor, has...
HIV reportedly “cured” in patient in London
For only the second time in the history of the AIDS pandemic, a patient with HIV in London seems to have been freed of...
Translation Inhibitors as Therapeutic Strategy
Cure Research with a Heart
Translation inhibitors may be part of a therapeutic strategy
by Jeannie Wraight
To date there are over 100 documented cases of HIV...
RIVER Study: Kick & Kill Vaccine Strategy
RIVER Dry
Kick and kill strategy study yields disappointing results
by Jeannie Wraight
Latent HIV resides in cells in blood and tissue which we collectively call the...
APPROACH Study
Mosaic Design
APPROACH, a preventive vaccine study, seeks to address more than one clade
by Jeannie Wraight
Over the past thirty-plus years, strategies such as Treatment as...
Broadly Neutralizing Antibodies
Another Road
Broadly neutralizing antibodies aim for a diverse effect against HIV types
by Jeannie Wraight and David Miller
Broadly neutralizing antibodies (bNAbs) hold the potential of...
Toxoplasmosis & HIV
A new study published in the Journal of Immunology suggests that co-infection with toxoplasmosis (toxo), a parasitic infection common in people with AIDS, may...
Cure Research: CROI 2018
Fast Look
Cure research highlights from CROI 2018
by Jeannie Wraight
The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...
Questioning the Cure
When first discussing the potential of writing a monthly column on HIV cure, my editor here at A&U Magazine asked a very valid question....
Imbokodo Study Launches
The Strength of Women
The Imbokodo Study launches in Southern Africa
by Jeannie Wraight
In Zulu, the word “Imbokodo” means “rock” and is part of a well-known...
LATEST POSTS
Global HIV and COVID-19 Emergency Response Fund
Global HIV and COVID-19 Emergency Response Fund
On April 27, 2020, ViiV Healthcare announced the creation of £3-million Global HIV and COVID-19 Emergency Response Fund...
